Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines

The development of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands for the treatment of diseases including metabolic syndrome, diabetes and obesity has been hampered due to contradictory findings on their potential safety. For example, while some reports show that ligand activation...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Girroir, Elizabeth E., Hollingshead, Holly E., Billin, Andrew N., Willson, Timothy M., Robertson, Gavin P., Sharma, Arun K., Amin, Shantu, Gonzalez, Frank J., Peters, Jeffrey M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2007
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2278023/
https://ncbi.nlm.nih.gov/pubmed/18054822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tox.2007.10.023
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk